Reyvow
Active substance: lasmiditan
TABLET · LASMIDITAN 100 mg/1
United StatesActive
Marketing holder: Eli Lilly and Company
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- LASMIDITAN · 100 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United StatescontrolledSchedule: CV
Source: openFDA NDC · record 01a1208e-af10-78be-8e90-53130ad8d343,01a1209e-0be9-7260-a7b0-7fc8e501a37f;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0002-4491
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CV
- Route
- ORAL
Sources
- product · openFDA NDC · 0002-4491 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0002-4491 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0002-4491 · Verified 2026-10-09 · open in source